Day One Biopharmaceuticals Inc
NASDAQ:DAWN
Income Statement
Earnings Waterfall
Day One Biopharmaceuticals Inc
Revenue
|
0
USD
|
Operating Expenses
|
-206.1m
USD
|
Operating Income
|
-206.1m
USD
|
Other Expenses
|
17.1m
USD
|
Net Income
|
-188.9m
USD
|
Income Statement
Day One Biopharmaceuticals Inc
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(14)
|
(28)
|
(41)
|
(57)
|
(73)
|
(84)
|
(106)
|
(126)
|
(147)
|
(165)
|
(178)
|
(189)
|
(206)
|
|
Selling, General & Administrative |
(5)
|
(7)
|
(12)
|
(20)
|
(29)
|
(38)
|
(47)
|
(55)
|
(61)
|
(67)
|
(69)
|
(70)
|
(76)
|
|
Research & Development |
(9)
|
(21)
|
(29)
|
(37)
|
(44)
|
(46)
|
(59)
|
(71)
|
(86)
|
(98)
|
(108)
|
(119)
|
(131)
|
|
Operating Income |
(14)
N/A
|
(28)
-104%
|
(41)
-47%
|
(57)
-38%
|
(73)
-28%
|
(84)
-16%
|
(106)
-25%
|
(126)
-19%
|
(147)
-16%
|
(165)
-12%
|
(178)
-8%
|
(189)
-7%
|
(206)
-9%
|
|
Pre-Tax Income | ||||||||||||||
Interest Income Expense |
(30)
|
(30)
|
(30)
|
(29)
|
0
|
0
|
0
|
2
|
5
|
8
|
11
|
15
|
17
|
|
Total Other Income |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Pre-Tax Income |
(44)
N/A
|
(58)
-32%
|
(71)
-23%
|
(86)
-22%
|
(73)
+16%
|
(84)
-16%
|
(105)
-25%
|
(124)
-18%
|
(142)
-15%
|
(157)
-10%
|
(166)
-6%
|
(175)
-5%
|
(189)
-8%
|
|
Net Income | ||||||||||||||
Income from Continuing Operations |
(44)
|
(58)
|
(71)
|
(86)
|
(73)
|
(84)
|
(105)
|
(124)
|
(142)
|
(157)
|
(166)
|
(175)
|
(189)
|
|
Income to Minority Interest |
3
|
4
|
(96)
|
(97)
|
(98)
|
(99)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(41)
N/A
|
(54)
-34%
|
(167)
-208%
|
(183)
-10%
|
(171)
+7%
|
(183)
-7%
|
(105)
+42%
|
(124)
-18%
|
(142)
-15%
|
(157)
-10%
|
(166)
-6%
|
(175)
-5%
|
(189)
-8%
|
|
EPS (Diluted) |
-0.67
N/A
|
-0.9
-34%
|
-2.69
-199%
|
-3.18
-18%
|
-4.62
-45%
|
-3.13
+32%
|
-1.73
+45%
|
-1.74
-1%
|
-2.17
-25%
|
-2.17
N/A
|
-2.21
-2%
|
-2.03
+8%
|
-2.37
-17%
|